FB
Francesca Barone sold $236K of CADL stock
Francesca Barone, Chief Scientific Officer of Candel Therapeutics, Inc. (CADL), sold 23,447 shares of CADL stock worth $236K, per an SEC Form 4 filed Jul 1, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 29, 2026, 2 days before it was made public.
CADL has moved -50.5% since the trade date, from $10.36 to $5.13 (Nov 19, 2026 close).
- Traded
- Jun 29, 2026
- Disclosed
- Jul 1, 2026
- Filing delay
- 2 days
- Price since
- -50.5%
- Role
- Chief Scientific Officer
- Source
- SEC Form 4